Nuray Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 1.20 M
- Revenue Growth -7.77%
- Profit Growth -5.80%
- Ebitda -9.54%
- Net Worth 67.63%
- Total Assets 31.19%
About Nuray Lifesciences
Nuray Lifesciences Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 December 2015 (Nine years and two months 24 days old ). Its registered office is in Nagpur, Maharashtra.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 M.
Ajay Valecha and Vinay Katakwar serve as directors at the Company.
Company Details
- Location Nagpur, Maharashtra
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74120MH2015PTC270587
- Company No.
270587
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2015
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nuray Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Valecha  | Director | 01-Dec-2015 | Current |
| Vinay Katakwar | Director | 01-Dec-2015 | Current |
Financial Performance of Nuray Lifesciences.
Nuray Lifesciences Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 7.77% decrease. The company also saw a slight decrease in profitability, with a 5.8% decrease in profit. The company's net worth Soared by an impressive increase of 67.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuray Lifesciences?
In 2021, Nuray Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jul 2017 | Indian Overseas Bank | ₹1.20 M | Open |
How Many Employees Work at Nuray Lifesciences?
Unlock and access historical data on people associated with Nuray Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuray Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuray Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
